These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 24379278)

  • 1. Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure.
    Testani JM; Brisco MA; Turner JM; Spatz ES; Bellumkonda L; Parikh CR; Tang WH
    Circ Heart Fail; 2014 Mar; 7(2):261-70. PubMed ID: 24379278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis.
    Brisco-Bacik MA; Ter Maaten JM; Houser SR; Vedage NA; Rao V; Ahmad T; Wilson FP; Testani JM
    J Am Heart Assoc; 2018 Sep; 7(18):e009149. PubMed ID: 30371181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials.
    Kiernan MS; Stevens SR; Tang WHW; Butler J; Anstrom KJ; Birati EY; Grodin JL; Gupta D; Margulies KB; LaRue S; Dávila-Román VG; Hernandez AF; de las Fuentes L;
    J Card Fail; 2018 Jul; 24(7):428-438. PubMed ID: 29482026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury.
    Ahmad T; Jackson K; Rao VS; Tang WHW; Brisco-Bacik MA; Chen HH; Felker GM; Hernandez AF; O'Connor CM; Sabbisetti VS; Bonventre JV; Wilson FP; Coca SG; Testani JM
    Circulation; 2018 May; 137(19):2016-2028. PubMed ID: 29352071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diuretic Response: Clinical and Hemodynamic Predictors and Relation to Clinical Outcome.
    Aronson D; Burger AJ
    J Card Fail; 2016 Mar; 22(3):193-200. PubMed ID: 26209003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substantial Discrepancy Between Fluid and Weight Loss During Acute Decompensated Heart Failure Treatment.
    Testani JM; Brisco MA; Kociol RD; Jacoby D; Bellumkonda L; Parikh CR; Coca SG; Tang WH
    Am J Med; 2015 Jul; 128(7):776-83.e4. PubMed ID: 25595470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An exploratory analysis of the competing effects of aggressive decongestion and high-dose loop diuretic therapy in the DOSE trial.
    Hanberg JS; Tang WHW; Wilson FP; Coca SG; Ahmad T; Brisco MA; Testani JM
    Int J Cardiol; 2017 Aug; 241():277-282. PubMed ID: 28392080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose of furosemide before admission predicts diuretic efficiency and long-term prognosis in acute heart failure.
    Blázquez-Bermejo Z; Farré N; Caravaca Perez P; Llagostera M; Morán-Fernández L; Fort A; de Juan Bagudá J; García-Cosio MD; Ruiz-Bustillo S; Delgado JF
    ESC Heart Fail; 2022 Feb; 9(1):656-666. PubMed ID: 34766460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure.
    Singh D; Shrestha K; Testani JM; Verbrugge FH; Dupont M; Mullens W; Tang WH
    J Card Fail; 2014 Jun; 20(6):392-9. PubMed ID: 24704538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients With Heart Failure.
    Testani JM; Hanberg JS; Cheng S; Rao V; Onyebeke C; Laur O; Kula A; Chen M; Wilson FP; Darlington A; Bellumkonda L; Jacoby D; Tang WH; Parikh CR
    Circ Heart Fail; 2016 Jan; 9(1):e002370. PubMed ID: 26721915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure.
    Woodruff AE; Kelley AM; Hempel CA; Loeffler WJ; Echtenkamp CA; Hassan AK
    Ann Pharmacother; 2016 Jun; 50(6):437-45. PubMed ID: 26956954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of forward flow and venous congestion in diuretic response in acute heart failure: Insights from the ESCAPE trial.
    Eder M; Griffin M; Moreno-Villagomez J; Bellumkonda L; Maulion C; Asher J; Wilson FP; Cox ZL; Ivey-Miranda JB; Rao VS; Butler J; Borlaug BA; McCallum W; Ramos-Mastache D; Testani JM
    Int J Cardiol; 2023 Jun; 381():57-61. PubMed ID: 37023862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diuretic Responsiveness and Its Prognostic Significance in Children With Heart Failure.
    Price JF; Younan S; Cabrera AG; Denfield SW; Tunuguntla H; Choudhry S; Dreyer WJ; Akcan-Arikan A
    J Card Fail; 2019 Dec; 25(12):941-947. PubMed ID: 30986498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
    Kissling KT; Pickworth KK
    Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First spot urine sodium after initial diuretic identifies patients at high risk for adverse outcome after heart failure hospitalization.
    Luk A; Groarke JD; Desai AS; Mahmood SS; Gopal DM; Joyce E; Shah SP; Lindenfeld J; Stevenson L; Lakdawala NK
    Am Heart J; 2018 Sep; 203():95-100. PubMed ID: 29907406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between high-dose loop diuretic use at discharge and cardiovascular mortality in patients with heart failure.
    Okabe T; Yakushiji T; Kido T; Oyama Y; Igawa W; Ono M; Ebara S; Yamashita K; Yamamoto MH; Saito S; Amemiya K; Isomura N; Ochiai M
    ESC Heart Fail; 2018 Feb; 5(1):87-94. PubMed ID: 28967699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients With Acute Decompensated Heart Failure (EMPAG-HF).
    Schulze PC; Bogoviku J; Westphal J; Aftanski P; Haertel F; Grund S; von Haehling S; Schumacher U; Möbius-Winkler S; Busch M
    Circulation; 2022 Jul; 146(4):289-298. PubMed ID: 35766022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolvaptan Improves Prognosis in Responders with Acute Decompensated Heart Failure by Reducing the Dose of Loop Diuretics.
    Nakamura M; Sunagawa O; Kinugawa K
    Int Heart J; 2018; 59(1):87-93. PubMed ID: 29375117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic Response Is Highly Variable and Associated With 6-Month Survival: Insights From the ROSE-AHF Trial.
    Hodson DZ; Griffin M; Mahoney D; Raghavendra P; Ahmad T; Turner J; Wilson FP; Tang WHW; Rao VS; Collins SP; Mullens W; Testani JM
    JACC Heart Fail; 2019 May; 7(5):383-391. PubMed ID: 31047017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.